These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38709719)
21. Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid. Ali A; An SJ; Cui C; Haque A; Carbis R Hum Vaccin Immunother; 2014; 10(6):1494-8. PubMed ID: 24603090 [TBL] [Abstract][Full Text] [Related]
22. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans. Wahid R; Fresnay S; Levine MM; Sztein MB Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480 [TBL] [Abstract][Full Text] [Related]
24. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)]. Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250 [No Abstract] [Full Text] [Related]
25. Status of paratyphoid fever vaccine research and development. Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427 [TBL] [Abstract][Full Text] [Related]
26. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216 [TBL] [Abstract][Full Text] [Related]
27. O:2-CRM(197) conjugates against Salmonella Paratyphi A. Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798 [TBL] [Abstract][Full Text] [Related]
28. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)]. Hatunceva NV; Mironova MV; Ryapolova RG Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248 [No Abstract] [Full Text] [Related]
29. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines. Zuckerman JN; Hatz C; Kantele A Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924 [TBL] [Abstract][Full Text] [Related]
30. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development. Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396 [TBL] [Abstract][Full Text] [Related]
31. Vaccines against typhoid fever. Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037 [TBL] [Abstract][Full Text] [Related]
34. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials. Arya SC; Agarwal N Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292 [No Abstract] [Full Text] [Related]
35. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid]. Kheĭfets LB; Stanislavskiĭ ES; Levina LA Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035 [No Abstract] [Full Text] [Related]
36. Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection. Gal-Mor O; Suez J; Elhadad D; Porwollik S; Leshem E; Valinsky L; McClelland M; Schwartz E; Rahav G Clin Vaccine Immunol; 2012 Feb; 19(2):146-56. PubMed ID: 22190395 [TBL] [